Radiotherapy enhanced tumor cell sensitivity to TRAIL by inducing expression of DR-4/DR-5 in human or DR-5 in mice confirmed in wide range of tumor such as lung, colon, head and neck, prostate and breast cancer. Here, TNFRSF10B is linked to breast cancer.